GS-6620, a liver-targeted nucleotide prodrug, exhibits antiviral activity and favorable safety profile over 5 days in treatment naive chronic HCV genotype 1 subjects

Authors
Category Primary study
JournalJournal of Hepatology
Year 2012
This article has no abstract
Epistemonikos ID: 7f7587ee5bc182c82ed5dbab7b23e017897f6be0
First added on: Feb 04, 2025